More recently, association of CD74 and MIF co-expression in lung cancers [10], and the identification of MIF by label-free proteomic approaches as one of many promising biomarkers in NSCLC [41], provides additional evidence of the importance of MIF in lung cancer development and progression. Here, CD74 is linked to lung cancer.